Nature Reviews Endocrinology

Papers
(The median citation count of Nature Reviews Endocrinology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Exposing skin to ultraviolet irradiation increases food intake in male individuals587
Non-nutritive sweeteners — too sweet to be wholesome?550
Dexamethasone in patients with diabetes mellitus510
Exercise-induced plasma factors confer brain benefits500
CNOT6L regulates hepatokine expression341
The role of DNA damage in diabetic complications335
Immune cell population prevents weight regain328
Memory of obesity stored in adipocytes328
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations304
Author Correction: Adrenocortical stem cells in health and disease298
Effects of diet on atherosclerotic plaque development283
Timed high-fat diet feeding restores small bowel circadian rhythms275
Limiting the use and misuse of liothyronine in hypothyroidism219
The gut microbiota in obesity and weight management: microbes as friends or foe?212
The challenges of assessing adiposity in a clinical setting166
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead166
Thyroid function and iodine intake: global recommendations and relevant dietary trends163
Type 2 diabetes mellitus in older adults: clinical considerations and management160
To fast or not to fast — that is the question156
Metformin reduces ageing adipose senescence146
Negative regulator of GDF15 signalling identified137
Iron in adipocytes — a role in gut–adipose crosstalk133
Ketosis improves muscle stem cell resilience130
Metabolite levels during the menstrual cycle127
Obesity phenotypes: explaining the unexplained127
The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects122
Reply to ‘Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines’120
Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines119
Research in metabolic ageing — a tale of mice versus humans?117
A pivotal year for NAFLD and NASH therapeutics116
The importance of human brown adipose tissue volume116
Role for exosomes in insulin sensitivity111
Neurons in the diagonal band of Broca moderate food intake111
Patients’ insights into diabetes insipidus106
Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy102
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus101
mTORC1 is the central regulator in pancreatic β-cells101
The interactions between energy homeostasis and neurovascular plasticity97
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease95
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity93
One hundred years of insulin therapy93
Primary aldosteronism — a multidimensional syndrome92
Steroid hormones as modulators of anti-tumoural immunity90
A role for phosphocreatine in adipose inflammation89
Ketogenic modification of the liver proteome84
Genetic risk scores improve prediction of obesity in survivors of childhood cancer83
New role for bone marrow adipocytes in obesity81
Role of extracellular vesicles in β-cell failure78
Signals from the dorsal motor nucleus of the vagus promote jejunal fat absorption77
A role for the kidney in metformin action76
Urocortin 3 function in glucose metabolism76
RalA links obesity and mitochondrial dysfunction75
Progress in islet transplantation is more important than ever73
The metabolic mythos of ketones72
GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus71
Stem-cell derived pancreatic endoderm cells in the treatment of T1DM67
Advances in basic biology and translation in islet research67
Inflammation-induced adrenal dysfunction66
Bone and muscle crosstalk in ageing and disease64
Advances in incretin-based therapeutics for obesity63
Targeting the incretin system in obesity and type 2 diabetes mellitus60
Endosomal trafficking in metabolic homeostasis and diseases59
Luteal phase support in assisted reproductive technology58
Untangling the pathways of SDHx loss of function54
The metabolic benefits of exercise-induced hepatic autophagy53
Triggering puberty in primates: is it NPY?53
Leptin–thyroid hormone axis affects energy use in muscle52
A multi-omics roadmap of β-cell failure in type 2 diabetes mellitus52
Potential downsides of calorie restriction50
REG3G — a potential link between the intestinal microbiome and host physiology49
Tracing the biological roots of obesity resistance in humans49
Skeletal and extraskeletal disorders of biomineralization48
Iatrogenic adrenal insufficiency in adults47
New insights into β-cell failure, regeneration and replacement46
A global view of hypertensive disorders and diabetes mellitus during pregnancy45
Islet hormones at the intersection of glucose and amino acid metabolism45
Length of light exposure alters energy metabolism in mice44
HIF1α inhibition preserves β-cell function44
Potential role for follicular Treg cells in T1DM43
Unravelling umami-induced obesity42
GLP1 receptor agonist overcomes SGLT2 inhibitor-related overeating41
Remission of T2DM requires early diagnosis and substantial weight reduction41
From the perspective of a scientist with Cushing disease, what did not kill me made my science stronger40
Obesity dysregulates a pituitary–liver axis through disruption of the unfolded protein response40
Melatonin prevents diabetes mellitus-induced bone loss39
Vitamin D supplementation and fracture risk38
Investigating the effects of artificial sweeteners37
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?37
Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?37
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus36
Lipid droplet biogenesis and functions in health and disease36
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice36
Sarcopenic obesity in older adults: a clinical overview35
At the 2022 Congress on Obesity35
Engineered Tregs prevent diabetes mellitus in mice35
GnRH pulses affect ageing in male mice32
Role of bile acids in controlling satiety31
Targeting senescent cells in ageing-related endocrine diseases30
Variation in serotonin 2C receptor linked with obesity and behaviour30
The glymphatic system as a nexus between obesity and neurological diseases30
Energy intake at the intersection of the clock and ageing28
Exosomes as novel biomarkers in metabolic disease and obesity-related cancers28
Large study on hormone therapy for transgender youth provides reassurance amid treatment politicization28
Molecular transducers and the cardiometabolic benefits of exercise28
Mitigating the environmental effects of healthcare: the role of the endocrinologist28
Sertoli cell lysosomal dysfunction drives age-related testicular degeneration26
Growth hormone-releasing hormone and its analogues in health and disease26
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?26
Metformin and GDF15: where are we now?26
New genes associated with adult-onset obesity25
Exercise in adults with type 1 diabetes mellitus25
Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities25
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency25
A protective role for insulin in acute pancreatitis24
The largest study of genetics of T1DM24
A mitochondrial trigger for beige adipocyte development22
Interventions in people newly diagnosed with type 1 diabetes mellitus21
GWAS gives insights into glucose regulation21
Mitochondria transported from adipocytes in extracellular vesicles21
Paracetamol use in pregnancy — caution over causal inference from available data20
Highlights from SfE BES 202120
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia20
TIM4+ adipose tissue-resident macrophages: new modulators of adiposity20
Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss20
Individualized and innovative gender healthcare for transgender and nonbinary youth19
The regulation of endocrine-disrupting chemicals to minimize their impact on health18
Medically not yet explained symptoms in hypothyroidism18
Brown adipose tissue fights the battle against leukaemia17
Sex differences in diabetic kidney disease explained17
Epigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment17
Combination therapy increases human β-cell mass in vivo16
SRC2 controls the refeeding response in mice16
Variation in metformin pharmacokinetics16
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia15
How COVID-19 disrupts glycometabolic control15
Masterful papers that broke open understanding of reproductive neuroendocrinology15
Metabolic effects of gender-affirming hormone therapy15
Environmental factors in declining human fertility14
Glial control of neuronal function14
Senescent immune cells promote skeletal ageing14
FGF1 signalling cascade suppresses lipolysis14
Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus14
The complex effects of dietary restriction on longevity and health14
New BAT–liver endocrine pathway via succinate14
A role for HDAC6 in leptin sensitivity14
Knowledge in youth is wisdom in age: involving young people in research14
Highlights from ADA 82nd Scientific Sessions14
Antioxidant liver myeloid cell population identified14
Dysfunctional lipid metabolism in ageing muscle: effects on glucose tolerance12
Author Correction: Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits12
AcroBATics: how dying brown adipocytes trigger browning12
Paracetamol use in pregnancy — neglecting context promotes misinterpretation12
An updated view on human neonatal thermogenesis12
The study that pioneered islet isolation techniques12
Obesity induces epigenetic memory in innate immune cells11
Bone fragility in type 2 diabetes mellitus: a lot left to explore11
Understanding the complexity of insulin resistance10
Endoscopic sleeve gastroplasty: safe and effective10
Targeting hyperglucagonaemia in T2DM10
CAMK1D required for ghrelin-mediated food intake10
Skeletal stem and progenitor cells in bone physiology, ageing and disease10
IL-17 has a role in whole-body homeostasis10
Genomics suggest role for IGF1 resistance in T2DM10
New variant for monogenic obesity10
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits10
Liothyronine treatment for hypothyroidism — a patient’s view9
Thyroid hormone action during development9
The intersection between ghrelin, metabolism and circadian rhythms9
Stem cells define adipose depot differences9
Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus9
Current and future pharmacotherapies for obesity in children and adolescents9
Pituitary stem cells: past, present and future perspectives9
Translational perspectives from TSHR, MCT8 and TRα research9
Thyroid dysfunction in COVID-199
Adipocytes enter the cell cycle in obesity9
Big data reveals a dominant link between education and diet quality8
Metabolic and feeding adjustments during pregnancy8
The physiological role of β-cell heterogeneity in pancreatic islet function8
The interplay between diabetes mellitus and menopause: clinical implications8
Weight stigma in healthcare settings is detrimental to health and must be eradicated8
Empowering early career researchers: academy-driven pathways to excellence8
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement8
Human stomach tissue as alternative source of insulin-producing cells8
Adipocyte-derived exosomes drive cancer metastasis7
Modelling human liver disease: from steatotic liver disease to MASH-HCC7
Deciphering the role of leptin in weight gain associated with anti-psychotic medications7
Control loop designs in health and disease7
Osteocalcin influences lifelong adrenal function7
A transporter on the move6
JNK at the helm: decoding obesity-driven insulin resistance6
Logic and mechanisms of metabolite signalling6
Glycogen involved in browning of adipocytes6
How the WHIMS clinical trial shaped the future of women’s health research6
Reply to ‘The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults’6
Endocrine effects of heat exposure and relevance to climate change6
Bile acid species shows potential for NAFLD6
Ghrelin’s effects on growth hormone release: to pulse or not to pulse?6
Intricacies and obscurities of non-shivering thermogenesis6
Potential gut–brain mechanisms behind adverse mental health outcomes of bariatric surgery6
PCOS — a metabolic condition with health impacts on women and men6
Brain–immune networks: a role for GLP1 receptor6
Adipose tissue lipolysis controlled by endothelial cells6
Optimising stem cells for diabetes mellitus therapy5
A century of glucagon5
Obesity-associated ASB4 controls satiety5
The influence of the circulatory system on tissue ageing: does the fountain of youth lie in our blood?5
The relationship between the gut microbiota and thyroid disorders5
Oxytocin regulates adipose tissue lipolysis5
Brain insulin action in women5
Cause of rare form of Cushing syndrome found5
Adrenal cysts: an emerging condition5
Low brown adipose tissue activity linked to NAFLD5
Exploring the functions of the myokine feimin5
Sex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus5
Defining subpopulations of human adipose tissue progenitor cells5
The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults5
Health equity in endocrinology5
New treatment target for endometriosis5
Nonenzymatic prevention of insulin hyperresponsiveness by FBP15
GLP1-mediated delivery of tesaglitazar improves glucose metabolism in mice5
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer5
Publisher Correction: Current understanding of the molecular and cellular pathology of diabetic retinopathy5
Succinate signalling regulates leptin production in adipocytes5
Insulin receptor sets liver clock5
Exerkines in health, resilience and disease5
Genomic alterations in thyroid cancer: biological and clinical insights4
Cognitive function in T1DM improved by hybrid closed-loop insulin delivery4
Ketogenic diet in cancer: insufficient stress response?4
Approval of teplizumab: implications for patients4
Diet composition affects mitochondria trafficking in adipose tissue4
Emerging mechanisms of obesity-associated immune dysfunction4
Follistatin linked to type 2 diabetes mellitus risk4
Debunking the myths of intermittent fasting4
Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus4
Consensus Statement on the definition and classification of metabolic hyperferritinaemia4
Autophagy in metabolic disease and ageing4
Highlights from SfE BES 20234
A new model predicts the best medication for patients with type 2 diabetes mellitus4
Early life factors that affect obesity and the need for complex solutions4
The role of regulated necrosis in endocrine diseases3
Promising findings in PTH replacement therapy trial3
Obesity induces systemic insulin resistance via endothelium-specific insulin receptor inhibition3
Metabolic alliance: pharmacotherapy and exercise management of obesity3
CCN3 maintains bone density during lactation3
Macrophages support pancreatic development3
Engineering adipocytes for cancer treatment3
Mitochondrial and metabolic dysfunction in ageing and age-related diseases3
GDF15 boosts muscle energy burn3
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification3
Inceptor loss in mice with obesity3
0.79670691490173